SCA Pharmaceuticals Recalls Heparin Sodium Bags Due to Low Potency
SCA Pharmaceuticals is recalling 3,932 bags of Heparin Sodium 5,000 units due to out-of-specification potency results at the 30-day stability timepoint.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II. While the rubric suggests Class II with hospitalization reports is Severe (4), this specific recall cites out-of-specification potency without reported hospitalizations or injuries, aligning with the High (3) criteria for risk-of-harm products where injury has not yet been reported.
Plain-English summary
SCA Pharmaceuticals is voluntarily recalling 3,932 bags of Heparin Sodium 5,000 units in 0.9% Sodium Chloride 1000 mL bag (5 units/mL), Rx only. The product is identified by NDC 70004-0650-46. The recall was initiated because the drug failed to meet potency specifications at the 30-day stability timepoint.
The affected lots include 1220018755, 1220018861, 1220018850, 1220018899, 1220019027, 1220019075, 1220019243, 1220019439, 1220019279, 1220019392, and 1220019488. These lots have expiration dates ranging from July 30, 2020, to August 26, 2020. The product was distributed nationwide within the United States.
Healthcare providers and patients should discontinue use of the affected lots and contact SCA Pharmaceuticals or their local FDA office for further instructions. This recall is classified as FDA Class II, indicating a reasonable probability that the use of the product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- Heparin Sodium 5,000 units in 0.9% Sodium Chloride 1000 mL bag (5 units/mL), Rx only, SCA Pharmaceuticals 755 Rainbow Rd. Windsor, CT 06095, NDC 70004-0650-46
- Manufacturer
- SCA Pharmaceuticals
- Category
- Drug — Anticoagulant
- Hazard
- Affected units
- 3,932
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (19)
- Lot #: 1220018755
- Exp. Date 7/30/2020
- 1220018861
- 1220018850
- Exp. Date 8/4/2020
- 1220018899
- Exp. Date 8/5/2020
- 1220019027
- Exp. Date 8/11/2020
- 1220019075
- Exp. Date 8/12/2020
- 1220019243
- Exp. Date 8/20/2020
- 1220019439
- 1220019279
- 1220019392
- Exp. Date 8/24/2020
- 1220019488
- Exp. Date 8/26/2020
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · SCA Pharmaceuticals
See all →- HighSCA Pharmaceuticals Fentanyl-Bupivacaine Injectable Recall Due to Manufacturing Deviations
FDA (Drugs) · 2023-08-02
- ModerateFDA recalls Oxytocin product for low potency nationwide
FDA (Drugs) · 2023-05-03
- ModerateFentanyl Injection Syringes Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2023-03-08
- ModerateNorepinephrine Injection Recalled Nationwide for Manufacturing Quality Deviations
FDA (Drugs) · 2022-05-11
- ModerateDrug recall: fentanyl and bupivacaine injectable solution manufacturing deviations
FDA (Drugs) · 2022-05-11
Same hazard · subpotent drug
See all →- ModerateAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02